Last updated: 2026-10-02 08:36:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
HeartSciences Inc. (HSCS) operates in the FINANCE SERVICES sector and is listed on NASDAQ. The stock is currently priced at $4.06, with a market capitalization of $20.25M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.63 to $5.25. This page covers its latest market performance, valuation, price trends and company information.
$20.25M | |
$3.91 | |
$600.00 | |
$1.63 | |
$3.89 | |
106.00 | |
110.78K | |
-- | |
$5.25 | |
$1.63 | |
-- | |
-- |
HeartSciences Inc. (HSCS) is trading at $4.06 in pre-market trading as of 2026-10-02 08:04:00, up 4.47% ($0.17) from the previous close of $3.89
Pre-market trading shows how investors are pricing HSCS before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, HeartSciences Inc. (HSCS) moved from $4.52 to $4.06, representing a decline of 10.09% ($0.46).
The stock traded between $3.80 and $5.03 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 121.92 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 67.2%
HSCS is currently trading at $4.06, placing it 67.2% of the way from its 52-week low of $1.63 to its 52-week high of $5.25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
| Industry | FINANCE SERVICES |
| Employees | 14 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of HeartSciences Inc. (HSCS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.